Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

aripiprazole

Known as: Aripiprazol, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone, Aripiprazole [Chemical/Ingredient] 
A quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
OBJECTIVE: The objective of this study was to evaluate short-term efficacy and safety of aripiprazole in the treatment of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2004
Review
2004
BACKGROUND Recently approved for the treatment of schizophrenia, aripiprazole represents the sixth second-generation… Expand
Highly Cited
2003
Highly Cited
2003
Atypical antipsychotic drugs have revolutionized the treatment of schizophrenia and related disorders. The current clinically… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2003
Highly Cited
2003
BACKGROUND Aripiprazole is a dopamine D2 receptor partial agonist with partial agonist activity at serotonin 5HT1A receptors and… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2003
Highly Cited
2003
Aripiprazole is a novel antipsychotic with a unique mechanism of action. Presented here is a pooled analysis of safety and… Expand
Review
2003
Review
2003
  • S. Woods
  • The Journal of clinical psychiatry
  • 2003
  • Corpus ID: 22959052
BACKGROUND Several clinical and research applications require an estimation of therapeutic dose equivalence across antipsychotic… Expand
Highly Cited
2002
Highly Cited
2002
Aripiprazole is the first next-generation atypical antipsychotic with a mechanism of action that differs from currently marketed… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2002
Highly Cited
2002
BACKGROUND Aripiprazole is an investigational agent for treating schizophrenia that has a novel pharmacologic profile. The… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Highly Cited
2002
Highly Cited
2002
Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinone, a novel antipsychotic with… Expand
Highly Cited
1999
Highly Cited
1999
OPC-14597 {aripiprazole; 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone} is a novel candidate… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2